ライフサイエンスコーパス: office visit

1 ronic messaging, and screening offers during office visits).

2 CNV activity identified by FFA and SD OCT by office visit.

3 or every 1.00 US dollars they receive for an office visit.

4 w Schedule, the Life Chart Interview, and an office visit.

5 teristics were recorded for each patient and office visit.

6 e that was completed by patients after their office visit.

7 is or, for controls, the date of the closest office visit.

8 ht up 82.4% of topics of interest during the office visit.

9 care team, and occurrence of a preoperative office visit.

10 d plasma testing had a blood draw during the office visit.

11 ervention and control groups at the 12-month office visit.

12 magnification was 4.32+/-1.15 at the last in-office visit.

13 measured using streak retinoscopy during an office visit.

14 by the health care provider during the same office visit.

15 d the nature of care they provide outside of office visits.

16 billing generated 36,297 US dollars from 730 office visits.

17 facility and claims data for related patient office visits.

18 o provide anticipatory guidance at pediatric office visits.

19 associated with a reduction in the length of office visits.

20 e visits, and 24.5% (95% CI, 24.5%-24.6%) of office visits.

21 Follow-up was performed via in-person office visits.

22 t commonly diagnosed condition at outpatient office visits.

23 n management has traditionally been based on office visits.

24 heckup at least twice a week at home between office visits.

25 isits, hospitalizations, deaths, and medical office visits.

26 ressing to PAC and cost and number of annual office visits.

27 what can be done during brief and infrequent office visits.

28 re, which was routine screening at in-person office visits.

29 tloading than non-frontloading, due to fewer office visits.

30 ted to lower prices paid by private PPOs for office visits.

31 nd 1.02% (95% CI, 0.57%-1.47%) for clinician office visits.

32 nd $1.18 (95% CI, $0.66-$1.70) for clinician office visits.

33 ts, advanced imaging services, and clinician office visits.

34 d imaging services and smallest for clinical office visits.

35 tients still require numerous injections and office visits.

36 linician alerts to replace some scheduled in-office visits.

37 ons, emergency department visits, and clinic office visits.

38 sting an association with elective follow-up office visits.

39 and no difference in payments for clinician office visits (0.26%; 95% CI; 0.53%-0.005%).

40 nificant increase in the per-member rates of office visits (0.7 per member per year; 95% CI, 0.6-0.7;

41 e 186 conditions seen in practice (0.74% for office visits; 0.51% for hospital stays).

42 ity by the time of their first postoperative office visit 1 week after surgery.

43 siderable health resources (median number of office visits, 11 and 7; median number of serologic test

44 .7%]) and/or saw the patient in a subsequent office visit (114 of 552 alerts [20.7%]).

45 were $4.8 million higher and expenditures on office visits $12.4 million higher (42% and 78% higher,

46 rson-months were 63.8 and 45.1 for physician office visits, 12.5 and 1.0 for emergency department vis

47 timated from the primary diagnosis for 13832 office visits (2010-2013 National Ambulatory Medical Car

48 ts are commonly used for clinical trials and office visits; 24- and 48-hour tests are more reliable a

49 avoid taking their children to a physician's office visit (3.8% vs. 31.6%; odds ratio, 0.07 [95% CI,

50 icians (53.1%) reported time pressure during office visits, 48.1% said their work pace was chaotic, 7

51 increase (95% CI) of 23.3% (2.04%-26.3%) in office visits, 5.8% (1.4%-10.2%) in emergency department

52 Genetic results were conveyed during an office visit (57%), by telephone (39%), or by mail (3%).

53 points; 95% CI, 28.0 to 47.8) and specialist office visits (67 of 158 [42.4%] vs 35 of 146 [24.0%]; R

54 s brought up QPL-related topics during their office visits (70.2% v 32.6%; P < .001).

55 points; 95% CI, -22.2 to -9.8), and more GP office visits (88 of 158 [55.7%] vs 26 of 146 [17.8%]; R

56 rom 330 antimicrobial prescriptions per 1000 office visits (95% CI, 305-355) to 234 (95% CI, 210-257;

57 averaged 6 additional eye-related outpatient office visits (95% CI: 5.7-6.2) resulting in an addition

58 scape, making diagnosis and treatment in one office visit a reality for TB.

59 0.40; 95% CI, -0.67 to -0.14; P = .003), and office visits (adjusted difference, -0.82; 95% CI, -1.54

60 Smokers with more office visits (adjusted OR, 2.44; 95% CI, 1.61-3.70) and

61 ren aged 12 years or younger with at least 1 office visit after lensectomy from June 2012 to July 201

62 ion were summarized from coaching notes; one office visit after the coaching session was audio record

63 Black patients had lower rates of vascular office visits after intervention (adjusted rate ratio, 0

64 Estimated rates of RSV-associated office visits among children under 5 years of age were t

65 We reviewed charts from office visits among patients who had a urine culture ord

66 Telephone interviews done after the index office visit and at 2, 4, 8, 12, and 24 weeks or until c

67 ntify high-risk individuals during a routine office visit and can be used to educate patients about m

68 dult-focused PCP visit (gap) for any type of office visit and for those that were preventive visits.

69 ld provide diagnostic information during the office visit and were compared with an acceptable criter

70 tegories of medical conditions seen in 13832 office visits and 108472 hospital stays with the percent

71 s cohort utilized a total of 5,108 physician office visits and 2,015 telephone calls.

72 ted median age at transfer of 21.8 years for office visits and 23.1 years for preventive visits and a

73 djusted median gap length of 20.5 months for office visits and 41.6 months for preventive visits.

74 Compared with standard follow-up through in-office visits and audible ICD alerts, remote monitoring

75 he traditional sporadic measures captured by office visits and hospitalizations.

76 cess that could readily be incorporated into office visits and in field settings to screen all youth

77 tients and account for a large percentage of office visits and increased medical costs.

78 on outpatient problem, resulting in frequent office visits and often requiring the use of prophylacti

79 ed to reduce the inequality between fees for office visits and payment for procedures, failed to prev

80 s (73%) met the inclusion criteria of annual office visits and received a mean of 5.8 +/- 2.5 intravi

81 istration of IVI during times when follow-up office visits and resources may be limited.

82 Between workshops, participants audiotaped office visits and studied the audiotapes.

83 l patients were followed longitudinally with office visits and telephone interviews.

84 Scheduled office visits and unscheduled evaluations, incidence of

85 screening, counseling or medications during office visits and used multiple logistic regression to a

86 oring reduces emergency department/urgent in-office visits and, in general, total healthcare use in p

87 ) completed the outcome assessment after the office visit, and 236 (76%) were followed for 6 months.

88 sulted in medication use, 27% resulted in an office visit, and 9% resulted in a referral to another p

89 gists have limited time with patients during office visits, and EHR use requires a substantial portio

90 lso had significantly more hospitalizations, office visits, and emergency department visits than both

91 cost-sharing levels for prescription drugs, office visits, and emergency department visits.

92 Higher neighborhood income level, physician office visits, and history of influenza vaccination (RR(

93 ergency department, hospital outpatient, and office visits; and (3) estimated days missed from work d

94 y disease accounts for 3.2% of all physician office visits annually and is the fourth leading cause o

95 a common ailment accounting for millions of office visits annually, including that of Mrs D, a 51-ye

96 roximately 400 000 ED visits and 1.7 million office visits annually, resulting in $284 million in hea

97 ion and treatment and use general outpatient office visits as an important opportunity to prevent tob

98 onditions during their initial and follow-up office visits as were 63 thyroid control patients.

99 All outpatient medical claims (office visits, associated diagnoses, and laboratory test

100 ces transmitted at 2-month intervals with an office visit at 6 months.

101 HM was used before office visits at 3 and 15 months in the HM group.

102 -up included 3-day Holter-ECG recordings and office visits at 3, 6, and 12 months.

103 -up included 3-day Holter ECG recordings and office visits at 3, 6, and 12 months.

104 rers tend to pay for procedures, but not for office visits, at higher levels than those paid by Medic

105 who were followed per standard of care with office visits augmented by transtelephonic monitoring (C

106 sts, advanced imaging services, or clinician office visits before receiving care for that service.

107 Patients with a first office visit between 2008 and 2010 were identified and f

108 Physician office visit billing generated 36,297 US dollars from 73

109 During the study period, the office visit blood pressure measurement target was 130/8

110 nteraction that do not depend on traditional office visits, but for which there are clear incentives.

111 edical Center, UPMC) among adults seen in an office visit by a UPMC-employed primary care physician (

112 Of 333735 adult patients seen in an office visit by PCPs in 2014, 53196 patients (15.9% of t

113 The proportion of clinicians and office visits by dermatology APCs and physician dermatol

114 or video appointment visits, or physician's office visits) by persons aged 18 years and older betwee

115 lizations, emergency department (ED) visits, office visits, chemotherapy, supportive care, and imagin

116 ing claims, and 26.8% of 2,653,227 clinician office visit claims were associated with a prior search

117 ream revenue was generated for every 1.00 of office visit compensation applied to the academic rheuma

118 Office visits comprised approximately one half, diagnost

119 examination questions and the percentages of office visit conditions or hospital stay conditions seen

120 dium-copay physician, and mean TPN physician office visit copay per patient.

121 y care physician (PCP) for routine care, PCP office visit copayment is $10 (otherwise, PCP office vis

122 ffice visit copayment is $10 (otherwise, PCP office visit copayment is $35 as for specialist visit);

123 ever, the bariatric group's prescription and office visit costs were lower and their inpatient costs

124 tween SG and RYGB in total ambulatory costs, office visit costs, or radiology costs in all follow-up

125 Herpes zoster was identified using a medical office visit diagnosis with treatment, and postherpetic

126 Extra in-office visits did not seem to be required to effectively

127 to a standardized audiotape depiction of an office visit during which they heard a physician who ass

128 edia (OM), the leading cause of primary care office visits during childhood, is critical to develop a

129 hypotensive therapy and avoiding unnecessary office visits during the COVID-19 pandemic.

130 ia at baseline and those with fewer than two office visits during the follow-up period.

131 of beneficiaries who underwent tests and had office visits during the preceding 11 months.

132 hereas model B was associated with increased office visits during the prenatal and postpartum periods

133 Intervention clinicians received 3 simulated office visits, each with a standardized patient instruct

134 ing) and 2 health care utilization measures (office visits, emergency department [ED] visits) were me

135 home health care, hospital outpatient care, office visits, emergency department use, and inpatient c

136 ions on the third or fourth day of life, and office visits, emergency department visits, and hospital

137 r of days hospitalized and hospitalizations, office visits, emergency department visits, death rate,

138 ed with the 142 eyes that did not undergo an office visit for a continuous 12-month period, eyes with

139 ean total retail cost of prescriptions at an office visit for acne was conservatively estimated to be

140 undergoing cataract surgery had a physician office visit for surgical clearance, and up to 23% of me

141 y database was used to estimate NMSC-related office visits for 2012.

142 een promotion of tegaserod and the number of office visits for abdominal pain, constipation, and bloa

143 % of emergency department visits, and 15% of office visits for acute respiratory infections from Nove

144 d corticosteroid use, outpatient physician's office visits for asthma, and asthma-related hospitaliza

145 Office visits for colds, upper respiratory tract infecti

146 ge, 1.7 to 13.8) of care provided outside of office visits for every 30 minutes of time spent schedul

147 he rate of emergency department or urgent in-office visits for heart failure, arrhythmias, or ICD-rel

148 ey, the authors identified 1,610 psychiatric office visits for patients who smoke.

149 ble amount of time providing care outside of office visits for patients with chronic illness.

150 linic visits, with slightly higher follow-up office visits for telemedicine but no difference in heal

151 fect and transferability: rapidly adjustable office visit frequency for unstable patients, close moni

152 odifiable hypertension management processes: office visit frequency, clinician treatment intensificat

153 Receiving the plurality of primary care office visits from a former chief PCP.

154 ntrol in patients presenting to primary care office visits from March 2018 to February 2020.

155 A nationally representative sample of office visits from the 1989 to 1996 National Ambulatory

156 oviders spend more time using the EHR for an office visit, generate longer notes, and close the chart

157 e visits, and 51.9% (95% CI, 51.8%-52.0%) of office visits had any medication prescribed; laboratory

158 n how telemedicine augmentation of in-person office visits has affected quality of patient care.

159 In this cross-sectional study, more office visits, having a chronic disease, and daily smoki

160 ed for assessing BCVA, or even the number of office visits if imaged remotely.

161 months, HM only was used but was followed by office visits if necessary.

162 Median EHR time per office visit in 2006 was 4.2 minutes (interquartile rang

163 The average duration of office visits in 1989 was 16.3 minutes according to the

164 tional analysis of 24.4 million primary care office visits in 2017 and performed comparisons between

165 of unilateral and bilateral studies per 100 office visits in each setting.

166 They provided 109 366 704 office visits in Medicare.

167 of life were assessed prospectively for all office visits (IndC = 230; UC = 5388) using previously r

168 pes of cost and use including prescriptions, office visits, laboratory encounters, and radiology.

169 alysis of e-visits and telephone, video, and office visits made in Kaiser Permanente Northern Califor

170 preexisting POAG, persons with XFG had more office visits (mean 9.3 vs 7.3; P < .0001), perimetry (8

171 ewly diagnosed POAG, those with XFG had more office visits (mean, 9.1 vs 7.9; P = .001), cataract sur

172 with chronic illness require care outside of office visits, much of which is not reimbursed under cur

173 9) completing patient record forms for adult office visits (n=28787).

174 mean cost of acne medications prescribed per office visit nationally and at an academic medical cente

175 An estimated 1.12 billion adult office visits occurred in 1991 and 1992 (95% confidence

176 nue loss of $126,000, increased revenue from office visits of $34,449 to $106,271 (minimum and maximu

177 For concordance between questions and office visits only, 2010 questions (58.08%; 95% CI, 56.4

178 Conventional patients were evaluated with office visits only.

179 ystitis in women can be diagnosed without an office visit or urine culture.

180 of conditions seen in practice during either office visits or hospital stays for each of 186 conditio

181 I, 2.40 to 3.55), and more frequent oncology office visits (OR, 3.14; 95% CI, 2.49 to 3.96).

182 ponsored trial involving 20 subjects with 17 office visits, or approximately 200 hours per subject.

183 We used physician office visit, outpatient department visit, and emergency

184 main utilization outcomes measured included office visits, outpatient surgeries, hospital admissions

185 +/- 2.70 EUA procedures versus 3.18 +/- 2.44 office visits per patient, compared to pre-iCare era rat

186 Including all types of office visits, price indexes at the 90th-percentile HHI

187 Direct (hospitalizations, office visits, procedures, and drug utilization) and ind

188 Direct (hospitalizations, office visits, procedures, and medications) and indirect

189 The proportion of dermatologic office visits provided by APCs also increased over time,

190 significant association between EHR use and office visit rates.

191 ns in ED visits and hospitalizations but not office visit rates.

192 io of 7.39 +/- 2.65 EUA versus 0.80 +/- 0.70 office visits, representing a 40% reduction in anesthesi

193 or a level 3 visit, defined as a new patient office visit requiring medical decision-making of low co

194 dules, and estimates of potential additional office visit revenue comparing immediate sequential cata

195 Independent of the office visit schedule, the interval for monitoring patie

196 tient self-care, maximizing effectiveness of office visits, selecting cost-effective diagnostic and t

197 continuous 12-month period, eyes with annual office visits showed similar baseline mean visual acuity

198 MAIN OUTCOME MEASURES: Rates of office visits, telephone encounters, after-hours clinic

199 erly patients, RSV infection generated fewer office visits than influenza; however, the use of health

200 was associated with more ED visits and fewer office visits than private Marketplace coverage, which m

201 l examinations was 2.21 times higher per 100 office visits than the rate of radiologist-referred bila

202 emale PCPs generated 10.9% less revenue from office visits than their male counterparts (-$39,143.2;

203 pressure (BP) variability from one physician office visit to the next (hereafter referred to as visit

204 of 140/90 mm Hg or higher obtained during an office visit to undergo a standardized antihypertensive

205 paid slightly lower mean (SD) copayments for office visits to a TPN physician than the patients with

206 lar trial eliminates the need for additional office visits to confirm the therapeutic effect.

207 an educational intervention using simulated office visits to encourage a watchful waiting approach f

208 and short counseling sessions during medical office visits to learn about osteoporosis.

209 racial disparities exist in the duration of office visits to psychiatrists is not known.

210 ovided during an estimated 547 million adult office visits to US physicians in 1995, including blood

211 care was associated with similar numbers of office visits, urgent care or emergency department visit

212 rtual care appointment; outpatient physician office visit; urgent care presentation; emergency depart

213 events (ED visits and hospitalizations) and office visit use among patients with diabetes, using mul

214 sing the EHR associated with each individual office visit using EHR audit logs and determined chart c

215 SD) of 2.1% (2.5%) vs 69.5% (18.6%) of their office visits virtually in the pandemic period.

216 Linear mixed models found EHR time per office visit was 31.9+/-0.2% (P < 0.001) greater from 20

217 total amount of downstream income from these office visits was 363,813 US dollars (47,386 US dollars

218 icipants in clinical interactions outside of office visits was collected on a structured form.

219 atients with angle-closure glaucoma, whereas office visits was the highest cost category among the "o

220 Using a national survey of office visits, we evaluated differences in the propensit

221 ations, and 460 000 outpatient and physician office visits were prevented.

222 A total of 531 pediatric office visits were recorded that included a principal di

223 ore than 1,800 dollars per survivor; medical office visits were the major component of costs.

224 Consultations and office visits were used to assess nonsurgical care, whil

225 und that medical treatment involved two more office visits, whereas surgical treatment could be more

226 ncreased far more rapidly than the volume of office visits, which benefits specialists who perform th

227 ma subspecialty practice for a nonprocedural office visit who consented to direct observation and 273

228 3 months of clinical follow-up, including an office visit with ECG every week or in cases of symptom

229 d electronic medical records to identify all office visits with an HZ diagnosis for children aged <18

230 ng treatment intensification rates to 62% of office visits with an uncontrolled blood pressure result

231 h specialty by private PPOs for intermediate office visits with established patients (Current Procedu

232 The reliability of 1 week of HBP, 3 office visits with mercury sphygmomanometry, and 24-h AB

233 e county-weighted mean price for 10 types of office visits with new and established patients (CPT cod

234 toring System (SMS) to examine the length of office visits with physicians from 1989 through 1998.

235 d the prevalence of preoperative testing and office visits with the mean percentage of beneficiaries

236 soft tissue sarcomas, patient education and office visits with thorough history and physical examina

237 ery short follow-up interval, often a single office visit, with variable and nonstandardized definiti

238 ne call within 6 days (utility, -0.49) or an office visit within 2 days (utility, -.53).

239 and lower than 90 mm Hg diastolic during an office visit within 6 months of an initial primary care

240 ed individuals with complete AF risk data, 2 office visits within 2 years, and no prevalent AF.

241 individuals with complete AF risk data, >=2 office visits within 2 years, and no prevalent AF.

242 eted records for >/=5 patients scheduled for office visits within 3 weeks for anti-VEGF injection or

243 Return office visits (within 30 days of the incident visit) for

244 all and high-cost health care encounters and office visits without affecting quality of life.